research Long-Term Efficacy of Baricitinib in Alopecia Areata: 3-Year Results from BRAVE-AA1 and BRAVE-AA2 September 2024 in “Journal of the American Academy of Dermatology” Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.
research Endocrinologic Diagnosis in Hirsutism and Androgenetic Alopecia in Women December 1990 in “PubMed”
